These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8633711)

  • 21. Tardive dyskinesia following brief exposure to risperidone--a case study.
    Karama S; Lal S
    Eur Psychiatry; 2004 Sep; 19(6):391-2. PubMed ID: 15363485
    [No Abstract]   [Full Text] [Related]  

  • 22. The treatment of tardive dyskinesia and tardive dystonia.
    Simpson GM
    J Clin Psychiatry; 2000; 61 Suppl 4():39-44. PubMed ID: 10739330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risperidone-induced tardive dyskinesia.
    Saran BM
    J Clin Psychiatry; 1998 Jan; 59(1):29-30. PubMed ID: 9491064
    [No Abstract]   [Full Text] [Related]  

  • 24. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 25. Chorea and tardive dyskinesia in a patient taking risperidone.
    Carroll NB; Boehm KE; Strickland RT
    J Clin Psychiatry; 1999 Jul; 60(7):485-7. PubMed ID: 10453805
    [No Abstract]   [Full Text] [Related]  

  • 26. Tardive dystonia provoked by concomitantly administered risperidone.
    Tachikawa H; Suzuki T; Kawanishi Y; Hori M; Hori T; Shiraishi H
    Psychiatry Clin Neurosci; 2000 Aug; 54(4):503-5. PubMed ID: 10997870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety of risperidone.
    Davidson M
    J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
    Peritogiannis V; Tsouli S
    J Clin Psychiatry; 2011 Jul; 72(7):1016; author reply 1016-7. PubMed ID: 21824463
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol.
    Tollefson GD; Beasley CM; Tamura RN; Tran PV; Potvin JH
    Am J Psychiatry; 1997 Sep; 154(9):1248-54. PubMed ID: 9286184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risperidone and tardive dyskinesia.
    Feeney DJ; Klykylo W
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421-2. PubMed ID: 8936904
    [No Abstract]   [Full Text] [Related]  

  • 33. Withdrawal-emergent respiratory dyskinesia with risperidone treated with clozapine.
    Mendhekar DN; Inamdar A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E24. PubMed ID: 20463136
    [No Abstract]   [Full Text] [Related]  

  • 34. Is there a real difference in severity of tardive dyskinesia between risperidone and olanzapine?
    Suzuki T; Takeuchi H; Watanabe K
    J Clin Psychiatry; 2010 Nov; 71(11):1553-4; author reply 1554. PubMed ID: 21114953
    [No Abstract]   [Full Text] [Related]  

  • 35. Tardive dyskinesia in affective disorders.
    Kane JM
    J Clin Psychiatry; 1999; 60 Suppl 5():43-7; discussion 48-9. PubMed ID: 10192407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tardive dyskinesia in patients with schizophrenia treated with olanzapine - results from a 20-month, prospective, open study under naturalistic conditions].
    Szafrański T
    Psychiatr Pol; 2014; 48(6):1155-65. PubMed ID: 25717485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risperidone-induced tardive dyskinesia.
    Buzan RD
    Am J Psychiatry; 1996 May; 153(5):734-5. PubMed ID: 8615429
    [No Abstract]   [Full Text] [Related]  

  • 39. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quetiapine treatment of risperidone-related tardive dyskinesia. A case report].
    Alcantara Lapaz AG; García Fernández L; Martínez MJ
    Actas Esp Psiquiatr; 2003; 31(5):306. PubMed ID: 14557956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.